KELLY K HUNT, M.D.
Radiology at Holcombe Blvd, Houston, TX
License number
Texas J6135
Category
Radiology
Type
Surgical Oncology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Organization information
See more information about KELLY K HUNT at bizstanding.comUniversity TX MD Anderson Cancer Center - Kelly K Hunt MD
1515 Holcombe Blvd UNIT 207, Houston, TX 77030
Categories:
Oncology Physicians & Surgeons
Phone:
(713) 792-6161 (Phone)
Professional information
Division Order Analyst
Location:
Houston, Texas Area
Industry:
Oil & Energy
Work:
Geomet Operating Co.
- Houston, Texas Area Nov 2008 - Jun 2012
-
Division Order Analyst
El Paso
2006 - 2008
-
Land Analyst
Education:
University of Phoenix 2002 - 2003
Bachelors, Business Administration
Bachelors, Business Administration
Kelly Kathleen Hunt, Houston TX
Specialties:
Surgery, Surgical Oncology, Public Health & General Preventive Medicine
Work:
M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston, TX 77030 MD Anderson Cancer Ctr
1400 Pressler St, Houston, TX 77030
1515 Holcombe Blvd, Houston, TX 77030 MD Anderson Cancer Ctr
1400 Pressler St, Houston, TX 77030
Education:
University of Tennessee (1986)
Pipeline Engineer At Fluor
Position:
Pipeline Engineer at Fluor
Location:
Houston, Texas Area
Industry:
Oil & Energy
Work:
Fluor
-
Pipeline Engineer
Education:
Texas A&M University 2002 - 2006
Kelly K Hunt, Houston TX
Specialties:
Surgeon
Address:
1515 Holcombe Blvd, Houston, TX 77030
1400 Pressler St, Houston, TX 77030
1400 Pressler St, Houston, TX 77030
Education:
University of Tennessee, College of Medicine - Doctor of Medicine
Ronald Reagan UCLA Medical Center - Residency - Surgery
Ronald Reagan UCLA Medical Center - Residency - Surgery
Board certifications:
American Board of Surgery Certification in Surgery
Low Molecular Weight Cyclin E (Lmw-E) As A Biomarker For Personalization Of Cancer Therapies
US Patent:
2012011, May 10, 2012
Filed:
Mar 10, 2010
Appl. No.:
13/255380
Inventors:
Khandan Keyomarsi - Houston TX, US
Nikki Delk - Houston TX, US
Kelly K. Hunt - Houston TX, US
Hannah Wingate - Humble TX, US
Elizabeth A. Mittendorf - Houston TX, US
Nikki Delk - Houston TX, US
Kelly K. Hunt - Houston TX, US
Hannah Wingate - Humble TX, US
Elizabeth A. Mittendorf - Houston TX, US
Assignee:
The Board of Regents of the University of Texas System - Austin TX
Research Development Foundation - Carson City NV
Research Development Foundation - Carson City NV
International Classification:
A61K 39/395, A61P 35/00, A61K 31/566, A61K 31/553, G01N 33/577, A61K 31/4196
US Classification:
4241331, 435 723, 514383, 514177, 51421108
Abstract:
Methods are disclosed for predicting a patient response to anti-Her2 therapy or anti-aromatase therapy. In certain embodiments, the methods involve the identification of low molecular weight cyclin E (LMW-E) in cancers, such as breast cancer cells, as a predictive and prognostic marker. In further embodiments, LMW-E expression by a cancerous or pre-cancerous cell may be used to predict response to an aromatase inhibitor and/or CDK2 inhibitor, and determination of LMW-E expression may be used in the personalization of cancer therapies.